LKB1, an upstream AMPK kinase, regulates glucose and lipid metabolism in cultured liver and muscle cells

Biochemical and Biophysical Research Communications

Volumn 351, Issue 3, 2006, Pages 595-601

  Imai, Kenta ^a   Inukai, Kouichi ^a   Ikegami, Yuichi ^a   Awata, Takuya ^a   Katayama, Shigehiro ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

AMPK; C2C12 myotubes; FAO cells; Gluconeogenesis; LKB1

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; BETA GALACTOSIDASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPID; PHENFORMIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE LKB1; THREONINE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CATALYSIS; CELL CULTURE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GLUCONEOGENESIS; GLUCOSE METABOLISM; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIPID METABOLISM; LIVER CELL; MAMMAL CELL; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CELL LINE; FEEDBACK; GLUCOSE; HEPATOCYTES; LIPID METABOLISM; MICE; MUSCLE FIBERS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

MAMMALIA;

EID: 33750698282     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.056     Document Type: Article

References (33)

1. Hardie D.G., and Carling D. The AMP-activated protein kinase: fuel gauge of mammalian cells. Eur. J. Biochem. 246 (1997) 259-273
2. Hardie D.G., Carling D., and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?. Annu. Rev. Biochem. 67 (1998) 821-855
3. Hardie D.G., Scott J.W., Pan D.A., and Hudson E.R. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546 (2003) 113-120
4. Winder W.W., and Hardie D.G. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am. J. Physiol. Endocrinol. Metab. 270 (1996) E299-E304
5. Hong Y.H., Varanasi U.S., Yang W., and Leff T. AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J. Biol. Chem. 278 (2003) 27495-27501
6. Xi X., Han J., and Zhang J.Z. Stimulation of glucose transport by AMP-activated protein kinase via activation of p38 mitogen-activated protein kinase. J. Biol. Chem. 276 (2001) 41029-41034
7. Baron S.J., Li J., Russell R.R., Neumann D., Miller E.J., Tuerk R., Wallimann T., Hurley R.L., Witter L.A., and Young L.H. Dual mechanism regulating AMPK kinase action in the ischemic heart. Circ. Res. 96 (2005) 337-345
8. Zou M.H., Hou X.Y., Chi C.M., Kirkpatick S., Liu F., Goldman M.H., and Cohen R.A. Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia- reoxygenation of bovine aortic endothelial cells: Role of peroxynitrite. J. Biol. Chem. 278 (2003) 34003-34010
9. 2. Biochem. Biophys. Res. Commun. 287 (2001) 92-97
10. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
11. Merrill G.F., Kurth E.J., Hardie D.G., and Winder W.W. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273 (1997) E1107-E1112
12. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174
13. Jenne D.E., Reimann H., Nezu J., Friedel W., Loff S., Jeschke R., Muller O., Back W., and Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 18 (1998) 38-43
14. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., Schlattner U., Wallimann T., Carison M., and Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13 (2003) 2004-2008
15. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., and Hardie D.G. Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2 (2003) 28
16. Boudeau J., Deak M., Lawlor M.A., Morrice N.A., and Alessi D.R. Heat shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem. J. 370 (2003) 849-857
17. Baas A.F., Boudeau J., Sapkota G.P., Smit L., Medema R., Morrice N.A., Alessi D.R., and Clevers H.C. Activation of the tumor suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J. 22 (2003) 3062-3072
18. Boudeau J., Scott J.W., Resta N., Deak M., Kieloch A., Komander D., Hardie D.G., Prescott A.R., Aalten D.M., and Alessi D.R. Analysis of the LKB1-STRAD-MO25 complex. J. Cell Sci. 117 (2004) 6365-6375
19. Inukai K., Shewan A.M., Pascow W.S., Katayama S., James D.E., and Oka Y. Carboxy terminus of glucose transporter 3 contains an apical membrane targeting domain. Mol. Endocrinol. 18 (2004) 339-349
20. Inukai K., Funaki M., Nawano M., Katagiri H., Ogihara T., Anai M., Onishi Y., Sakoda H., Ono H., Fukushima Y., Kikuchi M., Oka Y., and Asano T. The N-terminal 34 residues of the 55 kDa regulatory subunits of phosphoinositide 3-kinase interact with tubulin. Biochem. J. 346 (2000) 483-489
21. Inukai K., Asano T., Katagiri H., Anai M., Funaki M., Ishihara H., Tsukuda K., Kikuchi M., Yazaki Y., and Oka Y. Replacement of both tryptophan residues at 388 and 412 completely abolished cytochalasin B photolabeling of the GLUT1 glucose transporter. Biochem. J. 302 (1994) 355-361
22. Miyake S., Makimura M., Kanegae Y., Harada S., Sato Y., Takamori K., Tokuda C., and Saito I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA 93 (1996) 1320-1324
23. Sakoda H., Ogihara T., Anai M., Fujishiro M., Ono H., Onishi Y., Katagiri H., Abe M., Fukushima Y., Shojima N., Inukai K., Kikuchi M., Oka Y., and Asano T. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E1239-E1244
24. Lizcano J.M., Goransson O., Toth R., Deak M., Morrice N.A., Boudeau J., Hawley S.A., Udd L., Makela T.P., Hardie D.G., and Alessi D.R. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23 (2004) 833-843
25. Yamaguchi S., Katahira H., Ozawa S., Nakamichi Y., Tanaka T., Shimoyama T., Takahashi K., Yoshimoto K., Ohara M., Nagamatsu S., and Ishida H. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. AM. J. Physiol. Endocrinol. Metab. 289 (2005) E643-E649
26. Kahn B.B., Alquier T., Carling D., and Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 (2005) 15
27. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., and Hardie D.G. Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2 (2003) 28
28. Fryer L.G., Parbu-Patel A., and Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277 (2002) 25226-25232
29. Hawley S.A., Gadalla A.E., Olsen G.S., and Hardie D.G. The anti-diabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51 (2002) 2420-2425
30. 2+/dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2 (2005) 21-33
31. 2+/dependent protein kinase kinase beta. Mol. Cell Biol. 26 (2006) 5933-5944
32. Nakano M., Hamada T., Hayashi T., Yonemitsu S., Miyamoto L., Toyoda T., Tanaka S., Matsuzaki H., Ebihara K., Ogawa Y., Hosoda K., Inoue G., Yoshimasa Y., Otaka A., Fushiki T., and Nakao K. α2 isoform-specific activation of 5′ adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-d-ribonucleoside at a physiological level activates glucose transport and increase glucose transporter 4 in mouse skeletal muscle. Metabolism 55 (2006) 300-308
33. Jorgensen S.B., Viollet B., Andreelli F., Frosig C., Birk J.B., Schjerling P., Vaulont S., Richter E.A., and Wojtaszewski J.F. Knockout of the alpha2 but not alpha1 5′-AMP-activated protein kinase isoform abolishes 5-aminomidazole-4-carboxamide-1-beta-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem. 279 (2004) 1070-1079